BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng X, Wang L, Zhu B, Zhang J, Guo S, Li Q, Zhang T, Zheng Z, Wu G, Zhao Y. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:8657468. [PMID: 32462022 DOI: 10.1155/2020/8657468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fu J, Zhang J, Chen X, Liu Z, Yang X, He Z, Hao Y, Liu B, Yao D. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target. Theranostics 2023;13:787-809. [PMID: 36632213 DOI: 10.7150/thno.78840] [Reference Citation Analysis]
2 Paslaru L, Bindea G, Nastase A, Sorop A, Zimbru C, Herlea V, Hrehoret D, Brasoveanu V, Zamfir R, Dima S, Popescu I. Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. Medicina (Kaunas) 2022;58. [PMID: 36557005 DOI: 10.3390/medicina58121803] [Reference Citation Analysis]
3 Kakar MU, Mehboob MZ, Akram M, Shah M, Shakir Y, Ijaz HW, Aziz U, Ullah Z, Ahmad S, Ali S, Yin Y, Li K. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4237633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu H, Wen Q, Yan S, Zeng W, Zou Y, Liu Q, Zhang G, Zou J, Zou X. Tumor-Promoting ATAD2 and Its Preclinical Challenges. Biomolecules 2022;12:1040. [DOI: 10.3390/biom12081040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Deng M, Li S, Mei J, Lin W, Zou J, Wei W, Guo R. High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma. Genes (Basel) 2021;12:876. [PMID: 34200261 DOI: 10.3390/genes12060876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]